Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$1.27B |
| 2 |
QXO
QXO Inc
QXO
|
+$1.14B |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.06B |
| 4 |
Thermo Fisher Scientific
TMO
|
+$505M |
| 5 |
Walt Disney
DIS
|
+$502M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$1.46B |
| 2 |
NVIDIA
NVDA
|
+$938M |
| 3 |
Microsoft
MSFT
|
+$734M |
| 4 |
McDonald's
MCD
|
+$609M |
| 5 |
Chipotle Mexican Grill
CMG
|
+$544M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 3.37% |
| 2 | Healthcare | 3.33% |
| 3 | Consumer Discretionary | 2.43% |
| 4 | Financials | 2.27% |
| 5 | Industrials | 1.98% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
10701
PUT
Eagle Bancorp
EGBN
$878M
| $110K | ﹤0.01% |
5,800
-4,800
| -45% | -$93.4K |
|
10702
PUT
Wrap Technologies
WRAP
$105M
| $110K | ﹤0.01% |
54,800
-43,500
| -44% | -$75.5K |
|
|
KALV
10703
CALL
DELISTED
KalVista Pharmaceuticals
KALV
| $110K | ﹤0.01% |
9,300
-6,300
| -40% | -$73.5K |
|
10704
CALL
Liberty Latin America Class A
LILA
$1.69B
| $110K | ﹤0.01% |
16,781
+442
| +3% | +$2.46K |
|
10705
CALL
Invesco CurrencyShares British Pound Sterling Trust
FXB
$65M
| $110K | ﹤0.01% |
900
+100
| +13% | +$12.1K |
|
|
ITI
10706
DELISTED
Iteris, Inc.
ITI
| $109K | ﹤0.01% |
25,269
-10,377
| -29% | -$46.9K |
|
10707
CALL
INmune Bio
INMB
$60.2M
| $109K | ﹤0.01% |
12,400
-9,000
| -42% | -$88.7K |
|
|
CNTA
10708
CALL
DELISTED
Centessa Pharmaceuticals
CNTA
| $109K | ﹤0.01% |
12,100
-5,600
| -32% | -$53.1K |
|
10709
CALL
TriplePoint Venture Growth BDC
TPVG
$221M
| $109K | ﹤0.01% |
13,600
-84,200
| -86% | -$771K |
|
10710
CALL
Cricut
CRCT
$1.21B
| $109K | ﹤0.01% |
+18,200
| New | +$109K |
|
10711
CALL
Varex Imaging
VREX
$779M
| $109K | ﹤0.01% |
7,400
+500
| +7% | +$8.01K |
|
10712
PUT
Bank of N.T. Butterfield & Son
NTB
$2.51B
| $109K | ﹤0.01% |
3,100
-1,000
| -24% | -$33.5K |
|
10713
Gentex
GNTX
$5.03B
| $109K | ﹤0.01% |
3,228
+1,385
| +75% | +$47.8K |
|
10714
PUT
Regenxbio
RGNX
$711M
| $109K | ﹤0.01% |
9,300
-800
| -8% | -$12.5K |
|
10715
CALL
Veru
VERU
$46.5M
| $109K | ﹤0.01% |
12,930
-410
| -3% | -$4.74K |
|
10716
Beam Global
BEEM
$25.1M
| $109K | ﹤0.01% |
23,588
-18,547
| -44% | -$110K |
|
10717
CALL
EverCommerce
EVCM
$1.8B
| $109K | ﹤0.01% |
+9,900
| New | +$95.5K |
|
10718
InflaRx
IFRX
$301M
| $109K | ﹤0.01% |
62,425
-35,559
| -36% | -$52.2K |
|
10719
LENSAR
LNSR
$101M
| $109K | ﹤0.01% |
24,134
+15,809
| +190% | +$60.9K |
|
|
KDK
10720
Kodiak AI
KDK
$835M
| $108K | ﹤0.01% |
+10,168
| New | +$108K |
|
10721
Citius Pharmaceuticals
CTXR
$20.7M
| $108K | ﹤0.01% |
+7,425
| New | +$133K |
|
|
ELEV
10722
DELISTED
Elevation Oncology
ELEV
| $108K | ﹤0.01% |
40,113
-1,529,451
| -97% | -$5.76M |
|
10723
Advantage Solutions
ADV
$420M
| $108K | ﹤0.01% |
1,343
+745
| +125% | +$69.3K |
|
10724
CALL
Vanguard Total Bond Market
BND
$161B
| $108K | ﹤0.01% |
1,500
-5,100
| -77% | -$365K |
|
10725
CALL
iShares International Select Dividend ETF
IDV
$8.59B
| $108K | ﹤0.01% |
3,900
-51,700
| -93% | -$1.47M |
|
Similar funds
Ken Griffin's Q2 2024 Portfolio in Review
As of Q2 2024, Ken Griffin held 15,899 positions worth $494B, down 4.7% from $518B the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Ken Griffin withdrew a net $42.4B in Q2 2024, closing 1,760 positions and reducing 6,731 holdings. Its most notable exit was Pioneer Natural Resource Co., an estimated $1.46B position sold in full.
By sector, the portfolio is most concentrated in Technology at 3.4% of assets, down from 3.4% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Ken Griffin opened a new position in Carrier Global worth $140M.
- Ken Griffin's largest Q2 2024 buy was Carrier Global: 2,220,323 shares worth $140M.
- Ken Griffin added most to Invesco QQQ Trust in Q2 2024, an estimated $1.27B increase.
- Ken Griffin's biggest Q2 2024 reduction was NVIDIA, cutting an estimated $938M.
- Ken Griffin fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $1.46B.
- Ken Griffin's ten largest holdings make up 29% of its $494B portfolio in Q2 2024.
- Ken Griffin opened 1,434 new positions and closed 1,760 in Q2 2024.
- Ken Griffin's portfolio value fell 4.7% quarter-over-quarter to $494B.
Based on Citadel Advisors's 13F filing for Q2 2024, filed 14 Aug 2024.